Embedded Files
Trusted by MedTech companies navigating growth
✔ 20+ years executive leadership
✔ Australia • Europe • USA
✔ FDA • TGA • EU MDR
✔ AI • Digital Health • Medical Devices
✔ First-in-human to Commercial Launch
Commercialisation Strategy
Commercialisation Strategy
Successful commercialisation begins long before regulatory approval.
Avenir Health Strategies works alongside founders, CEOs and executive teams to develop integrated commercialisation strategies that align product development, regulatory requirements, clinical evidence and commercial objectives from the earliest stages.
We ensure every strategic decision contributes towards a common goal: bringing innovative technologies to market efficiently and successfully.
Our support includes:
Commercialisation roadmaps
Product development strategy
Market prioritisation
Global market entry sequencing
Regulatory and commercial alignment
Strategic planning for growth
Executive decision support
Executive Advisory
Executive Advisory
Growing MedTech companies often need executive-level expertise without the commitment of a full-time executive.
Avenir Health Strategies provides strategic advisory services to founders, executive leadership teams and Boards navigating periods of rapid growth, fundraising, product development and commercialisation.
We act as a trusted strategic partner, bringing an independent executive perspective informed by decades of leadership experience inside successful MedTech organisations.
We also support investors, incubators and commercialisation programmes evaluating regulatory, clinical and commercialisation strategies for emerging medical technologies.
Services include:
Executive coaching for founders
Strategic decision support
Fractional executive leadership
Board advisory
Investor readiness
Organisational growth planning
Operational scale-up
Leadership mentoring
Regulatory Strategy
Regulatory Strategy
Regulatory strategy should enable commercial success, not become a barrier to it.
We help companies navigate complex international regulatory frameworks while ensuring regulatory decisions support long-term business objectives.
Our experience spans FDA, TGA, EU MDR and other international regulatory systems across software, AI and medical devices.
Services include:
Regulatory pathway selection
FDA strategy
EU MDR strategy
TGA strategy
Global market access planning
Regulatory gap assessments
Submission planning
Regulatory authority engagement
Due diligence support
Clinical Strategy
Clinical Strategy
Clinical evidence should answer both regulatory and commercial questions.
We help companies develop practical clinical strategies that satisfy regulatory expectations while generating evidence that supports investor confidence, clinician adoption and reimbursement discussions.
Services include:
Clinical development strategy
Clinical investigation planning
Regulatory clinical requirements
Evidence generation strategy
First-in-human readiness
Clinical operations planning
Investigator engagement
Clinical risk assessment
Organisational Scale-Up
Organisational Scale-Up
Bringing a product to market requires an organisation capable of delivering consistently, efficiently and at scale.
As companies transition from research to clinical development and commercialisation, operational complexity increases rapidly. Manufacturing must become repeatable, suppliers must become reliable, and quality systems must support sustainable growth rather than slow it down.
Avenir Health Strategies helps leadership teams build the operational foundations required to support clinical studies, regulatory approvals and commercial launch.
Whether preparing for first manufacturing, selecting strategic suppliers or scaling operations following investment, we provide practical executive guidance that balances compliance with commercial realities.
Services include:
Operational scale-up strategy
Manufacturing readiness
Supply chain strategy
Supplier selection and qualification
Contract manufacturer selection and oversight
Outsourcing strategy
Procurement strategy
Operational risk assessment
Production planning
Quality system implementation and optimisation
ISO 13485 operational readiness
Executive operational mentoring
Training & Capability Building
Training & Capability Building
Almost every early MedTech start-up relies heavily on interns or early careers engineers – those teams are incredibly motivated but lack experienced mentors with deep knowledge of the highly regulated medical device industry.
Building internal capability is one of the most valuable investments a growing MedTech company can make, both enhancing skills capabilities and for talent retention.
Avenir Health Strategies develops practical education programmes that equip teams with the knowledge, confidence and strategic understanding required to contribute effectively from day one.
Training can be delivered as executive workshops, team programmes or structured online learning modules.
Topics include:
Introduction to Medical Device Regulations
FDA Fundamentals
EU MDR
Australian TGA Requirements
Clinical Investigations
ISO 13485
Risk Management
Design Controls
Software and AI Regulations
Regulatory Strategy
Commercialisation Fundamentals
Page updated
Google Sites
Report abuse